Table 1.

The SPHERE Study

Design	Randomised controlled trial.
Setting	General practices in Northern Ireland and Republic of Ireland.
Participants	903 patients with CHD within 48 practices.
Patient eligibility	Existing CHD (myocardial infarction, coronary artery bypass graft or angioplasty, angina). Patients with significant mental or physical illness excluded.
Intervention	Tailored care plans for practices (training in prescribing and behaviour change, administrative support, quarterly newsletter); tailored care plans for patients (motivational interviewing, goal identification, target setting, review four monthly until 18 month follow up).
Outcome measures	Included: primary: blood pressure, total cholesterol, hospital admissions; secondary: body mass index, exercise (Godin Leisure-Time questionnaire), diet (DINE questionnaire), smoking status.
Results	No significant differences between intervention and control groups relating to blood pressure and cholesterol. Hospital admissions for intervention group significantly decreased compared to control group.